Intelligent Neuromodulation Systems with AI, IoT, and Blockchain Integration

The present inventive concept integrates AI, IoT, and blockchain technologies with neuromodulation devices to create a more effective, personalized, and secure system for monitoring and controlling neuromodulation element deployment within a body lumen.

The original patent relates to devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen. However, the existing technology lacks the ability to provide personalized treatment planning, secure data management, and real-time adjustments. The present inventive concept addresses these limitations by incorporating AI-driven patient data analysis, IoT-enabled device control, blockchain-based data storage, and machine learning-based impedance analysis to ensure optimal energy delivery and secure data management.

The inventive concept comprises a neural network-based impedance analyzer, a blockchain-based data storage system, and an AI-powered sensor array integrated into a catheter. The impedance analyzer detects inadequate deployment and triggers a data storage event. The AI-driven patient data analysis integrates with IoT-enabled neuromodulation device control to optimize energy delivery based on individual patient characteristics. The machine learning-based impedance analysis module detects changes in tissue impedance and adjusts energy delivery in real-time. The blockchain technology ensures secure and decentralized neuromodulation data management, allowing for personalized treatment insights.

The present inventive concept is novel and non-obvious due to the integration of AI, IoT, and blockchain technologies with neuromodulation devices, providing a synergistic combination that enhances the effectiveness, personalization, and security of neuromodulation treatments. The inventive concept's use of machine learning-based impedance analysis, AI-driven patient data analysis, and blockchain-based data storage sets it apart from the original patent and existing technologies.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT protocols, or blockchain architectures. Variations could also include the integration of additional sensors or devices, such as electroencephalography (EEG) or electromyography (EMG) sensors, to provide more comprehensive patient data analysis.

The present inventive concept has significant commercial potential in the medical device industry, particularly in the fields of neuromodulation, cardiology, and neurology. The integration of AI, IoT, and blockchain technologies could provide a competitive advantage in the market, attracting customers seeking personalized and secure neuromodulation treatments.